Ann: Shareholder Briefings, page-33

Video would probably be good as he presents credibly and his passion is obvious. A true believer..!!

One of the difficulties I have is with that the science sounds REALLY amazing and they are doing top-shelf stuff, but that's really hard to communicate easily to those outside the scientific community. Then there is the obvious dichotomy between the science and the commercial story, which most of the investment community looks at, i.e. Buffet style. Now clearly that doesn't apply to PYC but mainstream fund managers, etc... will work more on that sort of mandate than backing a biotech as there is no real risk / return metric you can consider easily. Until they have any commercial story, which they do not really have now, it requires a leap of faith. i.e. it remains speculative.

Perhaps they'd be better off targeting the scientific community in general..?

Anyway, interesting times re the science and really enjoying watching that progress, even if the lack of action on the sp is frustrating at times.

Cheers